These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2421180)
1. [Cytocidal effect of bromocriptine on human pituitary adenoma cells. Light and electron microscopical studies in vitro]. Kabuto M; Kubota T; Hayashi M; Yamamoto S Neurol Med Chir (Tokyo); 1985 Nov; 25(11):886-93. PubMed ID: 2421180 [No Abstract] [Full Text] [Related]
2. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine. Li Q; Su Z; Liu J; Cai L; Lu J; Lin S; Xiong Z; Li W; Zheng W; Wu J; Zhuge Q; Wu Z Mol Cell Endocrinol; 2014 Jan; 382(1):377-384. PubMed ID: 24184771 [TBL] [Abstract][Full Text] [Related]
4. Bromocriptine-induced removal of endoplasmic membranes from prolactinoma cells. Landolt AM; Osterwalder V; Landolt TA Experientia; 1985 May; 41(5):640-2. PubMed ID: 3996537 [TBL] [Abstract][Full Text] [Related]
5. Attempt at pharmacological treatment of a pituitary tumor with bromocriptine. Pawlikowski M Endokrynol Pol; 1978; 29(5):413-6. PubMed ID: 710379 [No Abstract] [Full Text] [Related]
6. Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis. Mori H; Mori S; Saitoh Y; Arita N; Aono T; Uozumi T; Mogami H; Matsumoto K Cancer; 1985 Jul; 56(2):230-8. PubMed ID: 4005795 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules. Saitoh Y; Koizumi K; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H Anticancer Res; 1986; 6(5):1149-55. PubMed ID: 3800323 [TBL] [Abstract][Full Text] [Related]
8. [Morphological study of a prolactin-secreting pituitary adenoma after therapy with 2-bromo-alpha-erogocryptine (CB154) (author's transl)]. Beauvillain JC; Tramu G; Mazzuca M; Christiaens JL; L'Hermite ML; Asfour M; Fossati P; Linquette M Ann Endocrinol (Paris); 1976; 37(2):117-8. PubMed ID: 1036873 [TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinemia. Morphologic and clinical considerations. Ezrin C; Kovacs K; Horvath E Med Clin North Am; 1978 Mar; 62(2):393-408. PubMed ID: 205742 [No Abstract] [Full Text] [Related]
10. Bromocriptine therapy as pre-operative adjunct of non-functional pituitary macroadenomas. Zárate A; Morán C; Klériga E; Loyo M; González-Angulo A; Aquilar-Parada E Acta Endocrinol (Copenh); 1985 Apr; 108(4):445-50. PubMed ID: 3993311 [TBL] [Abstract][Full Text] [Related]
11. Pregnancy in an acromegalic after bromocriptine therapy. O'Herlihy C Ir J Med Sci; 1980 Jul; 149(7):281-2. PubMed ID: 7410043 [No Abstract] [Full Text] [Related]
12. In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas. García García J; Jiménez Reina L; García Luna PP; Leal Cerro A; Astorga Jiménez R; García García-Revillo J; Bernal Valls G Histol Histopathol; 1989 Apr; 4(2):223-33. PubMed ID: 2520459 [TBL] [Abstract][Full Text] [Related]
13. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study. Tindall GT; Kovacs K; Horvath E; Thorner MO J Clin Endocrinol Metab; 1982 Dec; 55(6):1178-83. PubMed ID: 6752167 [No Abstract] [Full Text] [Related]
14. Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study. Bassetti M; Spada A; Pezzo G; Giannattasio G J Clin Endocrinol Metab; 1984 Feb; 58(2):268-73. PubMed ID: 6693536 [TBL] [Abstract][Full Text] [Related]
15. Effect of bromocriptine on pituitary tumors. Ambrosi B; Nissim M; Arosio M; Faglia G JAMA; 1982 Sep; 248(9):1064-5. PubMed ID: 7109195 [No Abstract] [Full Text] [Related]
16. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report]. Takahashi T; Kuwayama A; Katoh T; Ichihara K; Kageyama N; Sasaki F No Shinkei Geka; 1984 Jan; 12(1):71-80. PubMed ID: 6717737 [TBL] [Abstract][Full Text] [Related]
17. The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro. Gruszka A; Kunert-Radek J; Radek A; Pisarek H; Taylor J; Dong JZ; Culler MD; Pawlikowski M Life Sci; 2006 Jan; 78(7):689-93. PubMed ID: 16115652 [TBL] [Abstract][Full Text] [Related]